These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36766711)

  • 1. Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review.
    Elvevi A; Laffusa A; Gallo C; Invernizzi P; Massironi S
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions.
    Cossiga V; Guarino M; Capasso M; Morisco F
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review).
    Yang S; Zou R; Dai Y; Hu Y; Li F; Hu H
    Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37888583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of cholangiocarcinoma carcinogenesis.
    Maemura K; Natsugoe S; Takao S
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):754-60. PubMed ID: 24895231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.
    Vicent S; Lieshout R; Saborowski A; Verstegen MMA; Raggi C; Recalcati S; Invernizzi P; van der Laan LJW; Alvaro D; Calvisi DF; Cardinale V
    Liver Int; 2019 May; 39 Suppl 1():79-97. PubMed ID: 30851232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumour microenvironment: a new vision for cholangiocarcinoma.
    Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G
    J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of Cholangiocarcinoma Immune Biology.
    Vita F; Olaizola I; Amato F; Rae C; Marco S; Banales JM; Braconi C
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
    Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
    Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
    Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNAs in cholangiocarcinoma.
    Liao W; Feng Q; Liu H; Du J; Chen X; Zeng Y
    Cancer Lett; 2023 Jan; 553():215980. PubMed ID: 36336149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
    Raggi C; Invernizzi P; Andersen JB
    J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis.
    Re OL; López-López V; Balaguer-Román A; Martínez-Sánchez MA; Eshmuminov D; Llamoza-Torres CJ; Miura K; Baroja-Mazo A; Ramírez P; Robles-Campos R; Ramos-Molina B
    Langenbecks Arch Surg; 2023 Mar; 408(1):134. PubMed ID: 37000331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of cholangiocarcinoma.
    Rizvi S; Gores GJ
    Dig Dis; 2014; 32(5):564-9. PubMed ID: 25034289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.
    Cao H; Huang T; Dai M; Kong X; Liu H; Zheng Z; Sun G; Sun G; Rong D; Jin Z; Tang W; Xia Y
    Int J Biol Sci; 2022; 18(14):5369-5390. PubMed ID: 36147461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
    Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, diagnosis and staging of cholangiocarcinoma.
    Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A
    Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions.
    Zhang G; Li J; Li G; Zhang J; Yang Z; Yang L; Jiang S; Wang J
    Clin Exp Med; 2024 Aug; 24(1):193. PubMed ID: 39141161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.